Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

PharmaCyte Biotech, Inc.

NASDAQ: PMCB · Life Sciences · 2 alerts · CIK 1157075

Share price
$5.57Close, Nov 16
Market cap
$59.8M
Shares outstanding
10.74MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All PharmaCyte Biotech, Inc. filings on SEC EDGAR ↗

4:28 PM ET 8-K
Reverse Stock Split

PharmaCyte Biotech Reverse Stock Split

PharmaCyte Biotech implemented a 1-for-19 reverse stock split of its common stock effective November 12, 2026. The split consolidated approximately 10.8 million outstanding shares into roughly 0.57 million shares to increase the per-share trading price. The action is intended to help the company regain compliance with the Nasdaq minimum bid price requirement for continued listing.

5:00 PM ET 8-K
Other 8-K Filing

PharmaCyte Biotech Other 8-K Filing

PharmaCyte Biotech dismissed CBIZ CPAs P.C. as its independent registered public accounting firm and appointed Grassi & Co., CPAs, P.C. as its new auditor. The change was approved by the Audit Committee on October 14, 2026, and the company reported no disagreements with the former auditor regarding accounting principles or practices.

Counterparty
Grassi & Co., CPAs, P.C.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.